You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lenalidomide

Showing 51 - 75 of 1,173
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Waldenström's Macroglobulinemia Trial in Busan (Lenalidomide, Bortezomib, Rituximab, Dexamethasone)

Recruiting
  • Waldenström's Macroglobulinemia
  • Lenalidomide, Bortezomib, Rituximab, Dexamethasone
  • Busan, Sue-gu, Korea, Republic of
    Kosin University Gospel Hospital
Mar 31, 2022

Mantle Cell Lymphoma, MCL Trial in United States (Tafasitamab, Lenalidomide)

Recruiting
  • Mantle Cell Lymphoma
  • MCL
  • Basking Ridge, New Jersey
  • +6 more
Mar 27, 2023

Relapsed/Refractory Marginal Zone Lymphoma Trial in Westbury (Zanubrutinib, Rituximab, Lenalidomide)

Recruiting
  • Relapsed/Refractory Follicular Lymphoma
  • Marginal Zone Lymphoma
  • Westbury, New York
    Clinical Research Alliance, Inc.
Nov 14, 2022

Multiple Myeloma, Myeloma Multiple, Myeloma Trial in Poitiers (Drug and medical device)

Not yet recruiting
  • Multiple Myeloma
  • +2 more
  • Drug and medical device
  • Poitiers, France
    CHU Poitiers
Jun 1, 2023

Plasma Cell Myeloma, Transplant-Related Carcinoma Trial in Seattle (Ixazomib Citrate, Laboratory Biomarker Analysis,

Active, not recruiting
Has Results
  • Plasma Cell Myeloma
  • Transplant-Related Carcinoma
  • Ixazomib Citrate
  • +2 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center
Jul 12, 2022

Multiple Myeloma Trial (Teclistamab, Daratumumab, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Oct 6, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Atlanta, Ann Arbor, Saint Louis (Dexamethasone, Ixazomib,

Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Atlanta, Georgia
  • +3 more
Jan 6, 2023

Multiple Myeloma Trial in New York (carfilzomib, Dexamethasone, Clarithromycin)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • New York, New York
    Weill Cornell Medical College
Apr 10, 2022

Rituximab, Lenalidomide, Zebutinib ,Mantle Cell Lymphoma Trial in Hangzhou (ZR2 RDHAP)

Recruiting
  • Rituximab, Lenalidomide, Zebutinib ，Mantle Cell Lymphoma
  • ZR2 RDHAP
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Aug 8, 2023

Multiple Myeloma Trial in Italy, Switzerland (Nelfinavir, Lenalidomide, Dexamethasone)

Terminated
  • Multiple Myeloma
  • Milano, Italy
  • +10 more
Jul 4, 2022

Grade 3a Follicular Lymphoma, Recurrent Follicular Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Houston (other,

Completed
  • Grade 3a Follicular Lymphoma
  • +9 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 31, 2023

Multiple Myeloma in Relapse Trial in Paris (Daratumumab/Lenalidomide/Dexamethasone for 24 months,

Recruiting
  • Multiple Myeloma in Relapse
  • Daratumumab/Lenalidomide/Dexamethasone for 24 months
  • Daratumumab/Lenalidomide/Dexamethasone until progression
  • Paris, France
    Saint Antoine Hospital - Hematology Department
Jun 10, 2022

Follicular Lymphoma Trial in Duarte, Irvine (procedure, other, biological, drug)

Not yet recruiting
  • Follicular Lymphoma
  • Biospecimen Collection
  • +7 more
  • Duarte, California
  • +1 more
Oct 27, 2023

Multiple Myeloma Trial (Isatuximab, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Apr 19, 2022

Multiple Myeloma Trial in Germany (Teclistamab (Tec), Daratumumab, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Teclistamab (Tec)
  • +4 more
  • Berlin, Germany
  • +8 more
Jan 19, 2023

MDS Trial in United States (Lenalidomide, Luspatercept)

Recruiting
  • Myelodysplastic Syndromes
  • Miami, Florida
  • +5 more
Sep 28, 2022

Relapsed or Refractory B-cell Non-Hodgkin Lymphoma Trial in Suzhou (Obinutuzumab, Zanubrutinib, Lenalidomide)

Enrolling by invitation
  • Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
  • Suzhou, Jiangsu, China
    the First Affiliated Hospital of Soochow University
Mar 22, 2023

Multiple Myeloma, Tumors, Tumor, Plasma Cell Trial (Belantamab Mafodotin-Blmf, Lenalidomide, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • +7 more
  • Belantamab Mafodotin-Blmf
  • +3 more
  • (no location specified)
Oct 11, 2022

Multiple Myeloma Trial in Rochester (procedure, biological, drug)

Not yet recruiting
  • Multiple Myeloma
  • Biospecimen Collection
  • +12 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Sep 15, 2023

Chronic Lymphocytic Leukemia(CLL), Small Lymphocytic Lymphoma Trial in Hackensack (Revlimid, Azacitidine)

Terminated
Has Results
  • Chronic Lymphocytic Leukemia(CLL)
  • Small Lymphocytic Lymphoma
  • Hackensack, New Jersey
    Hackensack University Medical Center
Jun 24, 2022

Partial Response of Multiple Myeloma or Plasma Cell Leukemia, Plasma Cell Myeloma Trial in Buffalo, Rochester (biological,

Active, not recruiting
  • Partial Response of Multiple Myeloma or Plasma Cell Leukemia
  • Plasma Cell Myeloma
  • Incomplete Freund's Adjuvant
  • +4 more
  • Buffalo, New York
  • +1 more
Dec 12, 2022

Multiple Myeloma, Relapsed Cancer, Refractory Multiple Myeloma Trial (ANV419, Lenalidomide with low-dose dexamethasone,

Not yet recruiting
  • Multiple Myeloma
  • +4 more
  • (no location specified)
Nov 29, 2022

Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma Trial in Chicago, Rochester, Cleveland (Venetoclax, Umbralisib, Ublituximab)

Terminated
  • Chronic Lymphocytic Leukemia
  • Non-Hodgkin Lymphoma
  • Chicago, Illinois
  • +2 more
Aug 19, 2022

Overall Survival Trial in Qingdao (Rituximab + zanubrutinib + lenalidomide)

Recruiting
  • Overall Survival
  • Rituximab + zanubrutinib + lenalidomide
  • Qingdao, Shandong, China
    Qingdao central Hospital
May 22, 2022

Plasma Cell Myeloma Trial in Buffalo (Belantamab Mafodotin, Lenalidomide)

Recruiting
  • Plasma Cell Myeloma
  • Belantamab Mafodotin
  • Lenalidomide
  • Buffalo, New York
    Roswell Park Cancer Institute
Dec 5, 2022